80 results
8-K
EX-99.1
SAVA
Cassava Sciences Inc
10 May 24
Cassava Sciences Reports Q1 2024 Financial Results and Clinical Updates on Phase 3 Trials of Simufilam
4:07pm
company based in Austin, Texas. Our mission is to detect and treat neurodegenerative diseases, such as Alzheimer’s disease. Our novel science is based
8-K
EX-99.1
SAVA
Cassava Sciences Inc
8 May 24
Cassava Sciences Announces Over $125 Million Raised from Warrant Distribution
4:05pm
on the Warrant distribution.
“We are grateful to so many shareholders who continue to show support for Cassava Sciences and its mission to develop a novel … mission is to detect and treat neurodegenerative diseases, such as Alzheimer’s disease. Our novel science is based on stabilizing—but not removing
8-K
EX-99.1
SAVA
Cassava Sciences Inc
1 May 24
Other Events
9:13am
, Texas. Our mission is to detect and treat neurodegenerative diseases, such as Alzheimer’s disease.
For more information, please visit: https
8-K
EX-99.1
SAVA
Cassava Sciences Inc
15 Apr 24
Redemption Date Announced for Warrants
4:01pm
mission is to detect and treat neurodegenerative diseases, such as Alzheimer’s disease. Our novel science is based on stabilizing—but not removing
8-K
EX-99.1
wsw74gz
28 Feb 24
Cassava Sciences Reports Full-year 2023 Financial Results and Corporate Updates
9:22am
8-K
EX-99.1
9uu4tfc
7 Feb 24
No Decline in Cognition Scores in Patients with Mild Alzheimer's Disease Who Received Simufilam Continuously For 24 Months
9:20am
424B2
ave9ugaqa3x94 lqor
3 Jan 24
Prospectus for primary offering
4:22pm
8-K
EX-99.1
whpxc8i 1e
12 Dec 23
Cassava Sciences Announces Dividend Distribution of Warrants to Shareholders
9:19am
8-K
EX-99.1
7fp nphgs
11 Dec 23
Cassava Sciences Appoints
4:18pm
8-K
EX-99.1
pq09lhg
7 Nov 23
Cassava Sciences Reports Third Quarter 2023 Financial and Operating Results
9:08am
8-K
EX-99.1
3vb gpum8
3 Aug 23
Cassava Sciences Reports Q2 2023 Financial Results and Operating Updates
9:12am
8-K
EX-99.1
o3cpf
5 Jul 23
Other Events
9:25am
424B5
hsokb
1 May 23
Prospectus supplement for primary offering
5:26pm
S-3ASR
94qv2mpspwsbgjk0q 7r
1 May 23
Automatic shelf registration
4:01pm
8-K
EX-99.1
4jap68nhcu4hk4
1 May 23
Cassava Sciences Reports Q1 2023 Financial Results and Operating Updates
9:05am